Literature DB >> 760740

Impaired theophylline clearance in patients with cor pulmonale.

N Vicuna, J L McNay, T M Ludden, H Schwertner.   

Abstract

1 The relationship between serum theophylline concentration and daily dose was studied in 45 patients receiving aminophylline orally and in 36 patients receiving it by constant intravenous infusion. 2 Patients were categorized as uncomplicated chronic obstructive pulmonary disease (COPD) or COPD with cor pulmonale (CP). 3 Serum theophylline concentration relative to daily theophylline dose was significantly higher in patients with COPD plus CP than in patients with COPD alone. 4 Total body clearance of theophylline estimated from data obtained during constant intravenous infusion was significantly lower in COPD plus CP than in patients with COPD alone. 5 We conclude that reduced maintenance doses of theophylline are indicated in patients with COPD when complicated with CP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760740      PMCID: PMC1429611          DOI: 10.1111/j.1365-2125.1979.tb00893.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Determination of theophylline in plasma by electron capture gas chromatography.

Authors:  H A Schwertner; T M Ludden; J E Wallace
Journal:  Anal Chem       Date:  1976-11       Impact factor: 6.986

3.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

4.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Theophylline-induced seizures in adults. Correlation with serum concentrations.

Authors:  C W Zwillich; F D Sutton; T A Neff; W M Cohn; R A Matthay; M M Weinberger
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

6.  Hemodynamic effects of aminophylline in cor pulmonale.

Authors:  J O Parker; K Kelkar; R O West
Journal:  Circulation       Date:  1966-01       Impact factor: 29.690

7.  Theophylline disposition in patients with hepatic cirrhosis.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

8.  Theophylline kinetics in acute pulmonary edema.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

9.  Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

Authors:  P M Loughnan; D S Sitar; R I Ogilvie; A Eisen; Z Fox; A H Neims
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

  9 in total
  13 in total

1.  Advocating for patients through clinical research.

Authors:  Leslie Hendeles
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

2.  Fatal theophylline toxicity precipitated by in situ pulmonary artery thrombosis.

Authors:  R J Davies; C J Hawkey
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

Review 3.  Theophylline.

Authors:  E F Ellis
Journal:  Clin Rev Allergy       Date:  1983-03

4.  Slow release theophyllines and chronic bronchitis.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

5.  Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.

Authors:  M A Butcher; L A Frazer; H K Reddel; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

6.  Pharmacokinetics of a single evening dose of slow release theophylline in patients with chronic lung disease.

Authors:  P J Thompson; M A Butcher; L A Frazer; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

Review 7.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 9.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 10.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.